Accessibility Menu
Edap Tms logo

Edap Tms(NASDAQ) FOCL

Market Cap$233.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-27%
5 Year+7%
1 Year+388%
1 Month+12%
$6.24
+2.30%
+0.14Today
Edap Tms last closing stock price
MetricPriceDate
Last closeUSD 6.082026-08-10
Edap Tms stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.84%USD 5.972026-08-03
1 month+11.87%USD 5.442026-07-10
3 month+49.02%USD 4.082026-05-12
Year to date+84.8%USD 3.292025-12-31
1 year+388.35%USD 1.252025-08-08
3 year-23.9%USD 7.992023-08-11
5 year+7.42%USD 5.662021-08-11
Since inception-26.82%USD 8.501997-08-01

Edap Tms Financials at a Glance

Market Cap

$233.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$74.14M

Net Income (TTM)

-$30.77M

EPS (TTM)

-$0.82

P/E Ratio

-7.57

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$6.24

Volume

39,150.393

Open

$6.25

Previous Close

$6.08

Daily Range

$6.08 - $6.28

52-Week Range

$1.26 - $6.40

Estimated Earnings Date

Aug 26, 2026

FOCL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Edap Tms

Edap TMS makes medical devices that treat prostate cancer and urinary stones. Its products help hospitals and clinics offer less invasive treatments. Patients benefit from quicker recovery and fewer complications compared to traditional surgery.

Gadgets That Matter: Products and Services

  • HIFU Systems: Devices using focused ultrasound to treat prostate cancer without surgery, mainly for hospitals and urology clinics.
  • ESWL Devices (10.6% of revenue): Machines that break up urinary stones using shockwaves, targeting small and mid-size hospitals.
  • Distribution Services (36.5% of revenue): Sales and support for third-party medical products like lasers and ultrasound systems, serving clinics and research centers.
  • Consumables and Maintenance: Single-use parts and ongoing service contracts for device upkeep, supporting recurring revenue.
  • Leasing and Treatment Services: Equipment leasing and procedure-based services for healthcare providers needing flexible access.

Plot Twists: Growth and Expansion

  • Launched Focal One i Robotic HIFU System, designed to support future AI features, in 2025.
  • Received FDA and CE Mark approvals for new uses, including endometriosis, in 2024 and 2025.
  • Maintains direct sales in the United States, France, Germany, and Asia.
  • Renewed main manufacturing facility lease in Vaulx-en-Velin, France, for nine years in 2024.
  • Shifted focus to HIFU segment and reduced ESWL and distribution activities in 2025.

Why Edap TMS Stands Out

Edap TMS operates globally, selling through both direct subsidiaries and third-party distributors. The company invests heavily in research, focusing on AI and advanced imaging. Its recurring revenue model relies on equipment sales, consumables, and maintenance contracts.

Five Things You Need to Know

  • Revenue was $70.5 million in 2025, up 1.6% from 2024.
  • HIFU sales rose 44.8% in 2025, making up 53.1% of revenue.
  • Gross margin improved to 42.5% in 2025, up from 41.4% in 2024.
  • Net loss increased to $29.2 million in 2025, from $20.6 million in 2024.

Bottom Line

Edap TMS has shifted toward higher-margin, minimally invasive therapies and recurring revenue streams. The company continues to adapt through innovation and global expansion.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

289

CEO

Ryan Rhodes

Website

www.focalone.com

Headquarters

Vaulx-en-Velin, ARA 69120, FR

FOCL Financials

Key Financial Metrics (TTM)

Gross Margin

43.42%

Operating Margin

-34.67%

Net Income Margin

-41.50%

Return on Equity

-137.53%

Return on Capital

-53.53%

Return on Assets

-42.70%

Earnings Yield

-13.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$233.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

37.48M

Volume

39.15K

Avg. Volume

47.66K

Financials (TTM)

Gross Profit

$32.19M

Operating Income

-$25.70M

EBITDA

-$24.59M

Operating Cash Flow

-$17.38M

Capital Expenditure

-$4.57M

Free Cash Flow

-$21.94M

Cash & ST Invst.

$15.01M

Total Debt

$27.79M

Edap Tms Performance Analysis

Edap Tms annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 57,917,09311.2%
20232023-12-31USD 65,324,24812.8%
20242024-12-31USD 69,352,6036.2%
20252025-12-31USD 70,745,2252.0%
Edap Tms sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3027.4%
Q32025-09-30-10.8%
Q42025-12-3134.8%
Q12026-03-31-18.2%
Edap Tms annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.09N/A
20232023-12-31USD -0.62590.7%
20242024-12-31USD -0.55-10.9%
20252025-12-31USD -0.7842.0%
Edap Tms sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3015.0%
Q32025-09-305.9%
Q42025-12-31-56.3%
Q12026-03-314.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$17.88M

+25.3%

Gross Profit

$8.18M

+36.4%

Gross Margin

45.73%

N/A

Market Cap

$233.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$806.71K

N/A

Employees

289

N/A

Net Income

-$9.12M

-22.4%

EBITDA

-$6.35M

+13.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$15.01M

-39.2%

Total Debt

$27.79M

+182.9%

Accounts Receivable

$20.33M

+15.9%

Inventory

$13.33M

-31.7%

Long Term Debt

$19.95M

+443.5%

Short Term Debt

$7.84M

+27.4%

Return on Assets

-42.70%

N/A

Return on Invested Capital

-74.39%

N/A

Free Cash Flow

-$3.74M

+29.1%

Operating Cash Flow

-$2.98M

+26.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,747.67-0.00%
^DJIDJI
$53,859.14-0.00%
^IXICNASDAQ
$26,571.33-0.00%
BTCBitcoin
$63,877.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$138.74+0.04%
ACHRArcher Aviation
$6.26+0.12%
NVDANvidia
$217.55-0.03%
INTCIntel
$97.52-0.04%

Questions About FOCL

What is the current price of Edap Tms?

Edap Tms is trading at $6.08 per share.

What is the 52-week range for Edap Tms?

Over the past 52 weeks, Edap Tms has traded between $1.26 and $6.40.

How much debt does Edap Tms have?

As of the most recent reporting period, Edap Tms reported total debt of $27.79M.

How much cash does Edap Tms have on hand?

Edap Tms reported $15.01M in cash and cash equivalents in its most recent financial results.

What is Edap Tms’s dividend yield?

Edap Tms does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services